PMC5863301_01
Breast and chest wall invasion accompanied by ulcer and infection are shown. (a) BMC after one week of treatment, on September 30, 2016; (b) BMC after one month of treatment, on October 18, 2016; (c) BMC after four months of treatment, on January 11, 2017.
CRIONM2018-8759564.001.jpg
PMC5863301_01_CRIONM2018-8759564.001.jpg
fig1
The large tumor had already occupied the bilateral breasts, and the bilateral chest walls and abdominal wall were invaded (Figure 1); computed tomography (CT) showed bilateral pleural fluid, multilung metastasis, right pulmonary vein invasion, and pericardium invasion (Figure 2). Bilateral breast and chest invasion was stable (Figures 1 and 1).
CT scan showed bilateral lung metastasis and pleural fluid. (a) Massive right pleural fluid and bilateral breast metastasis were detected before treatment on September 22, 2016; (b) massive right pleural fluid mostly disappeared, and bilateral breast metastasis was stable after three weeks of treatment, on October 14, 2016; (c) No further observation of right pleural fluid was made, and bilateral breast metastasis was stable after four months of treatment, on January 26, 2017; (d) No further occurrence of right pleural fluid or lung metastasis was noted, and bilateral breast metastasis was stable after seven months of treatment, on April 27, 2017.
CRIONM2018-8759564.002.jpg
PMC5863301_01_CRIONM2018-8759564.002.jpg
fig2
The large tumor had already occupied the bilateral breasts, and the bilateral chest walls and abdominal wall were invaded (Figure 1); computed tomography (CT) showed bilateral pleural fluid, multilung metastasis, right pulmonary vein invasion, and pericardium invasion (Figure 2). Massive pleural fluid almost disappeared (Figures 2-2) from October 14, 2016, to April 27, 2017, and the patient has almost recovered from dyspnea and cachexia. CT scan showed that the primary tumor was stable, and no new metastasis occurred (Figures 2-2) from October 14, 2016, to April 27, 2017.
(a) NRS score showed that the pain had improved gradually and dramatically after 11 days of treatment. (b) ECOG score showed that QOL had improved and remained stable.
CRIONM2018-8759564.003.jpg
PMC5863301_01_CRIONM2018-8759564.003.jpg
fig3
Meanwhile, ECOG and NRS pain scores decreased to 2 and 2 (Figure 3), respectively.